These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37562556)
1. Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy. Cheng Y; Zou J; He M; Hou X; Wang H; Xu J; Yuan Z; Lan M; Yang Y; Chen X; Gao F J Control Release; 2024 Mar; 367():167-183. PubMed ID: 37562556 [TBL] [Abstract][Full Text] [Related]
2. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy. Hou X; Shou C; He M; Xu J; Cheng Y; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F Acta Pharm Sin B; 2020 Sep; 10(9):1741-1753. PubMed ID: 33088693 [TBL] [Abstract][Full Text] [Related]
3. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy. He M; Wang Y; Chen X; Zhao Y; Lou K; Wang Y; Huang L; Hou X; Xu J; Cai X; Cheng Y; Lan M; Yang Y; Gao F J Control Release; 2020 Mar; 319():1-14. PubMed ID: 31838205 [TBL] [Abstract][Full Text] [Related]
4. Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system. Cheng Y; Sun R; He M; Zhang M; Hou X; Sun Y; Wang J; Xu J; He H; Wang H; Lan M; Zhao Y; Yang Y; Chen X; Gao F Int J Pharm; 2022 Apr; 618():121613. PubMed ID: 35217071 [TBL] [Abstract][Full Text] [Related]
5. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer. Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420 [TBL] [Abstract][Full Text] [Related]
6. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment. Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321 [TBL] [Abstract][Full Text] [Related]
7. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis. Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527 [TBL] [Abstract][Full Text] [Related]
8. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition. Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626 [TBL] [Abstract][Full Text] [Related]
9. pH-responsive Sulfated Hyaluronic Acid Nanoparticles Targeting Tumor Cells and CAFs for the Treatment of Breast Cancer. Wang D; Wu J; Qi C; Dong J; Ding X; Yu G; Liu S; Zhang B; Gao Z; Wei X; Liu H Recent Pat Anticancer Drug Discov; 2022; 18(2):200-210. PubMed ID: 35538821 [TBL] [Abstract][Full Text] [Related]
10. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597 [TBL] [Abstract][Full Text] [Related]
11. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer. Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway. Pradhan R; Paul S; Das B; Sinha S; Dash SR; Mandal M; Kundu CN J Nutr Biochem; 2023 Mar; 113():109257. PubMed ID: 36572069 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of an Integrin α Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615 [TBL] [Abstract][Full Text] [Related]
14. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy. Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810 [TBL] [Abstract][Full Text] [Related]
15. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Takai K; Le A; Weaver VM; Werb Z Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881 [TBL] [Abstract][Full Text] [Related]
16. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer. Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002 [TBL] [Abstract][Full Text] [Related]
17. Fine tuning the LightOn light-switchable transgene expression system. Ma Z; Du Z; Chen X; Wang X; Yang Y Biochem Biophys Res Commun; 2013 Oct; 440(3):419-23. PubMed ID: 24095689 [TBL] [Abstract][Full Text] [Related]
18. Normalizing Tumor Blood Vessels to Improve Chemotherapy and Inhibit Breast Cancer Metastasis by Multifunctional Nanoparticles. Zeng Y; Zhang S; Li S; Song G; Meng T; Yuan H; Hu F Mol Pharm; 2023 Oct; 20(10):5078-5089. PubMed ID: 37728215 [TBL] [Abstract][Full Text] [Related]
19. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer. Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453 [TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy. Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]